28,495 results on '"antibodies"'
Search Results
2. Patent Application Titled 'Bispecific Anti-Ccl2 Antibodies' Published Online (USPTO 20240360208)
3. Merck enters into exclusive global license with LaNova Medicines to develop, manufacture & commercialize LM-299, an investigational anti-PD-1/VEGF bispecific antibody
4. Bird flu antibodies found in US dairy workers without any symptoms
5. Bird flu antibodies found in US dairy workers without any symptoms
6. Study Findings from Research and Development Department Provide New Insights into Apoptosis (Beyond ADCs: Harnessing Bispecific Antibodies to Directly Induce Apoptosis for Targeted Tumor Eradication)
7. Reports Summarize Encephalitis Research from University of Oxford (Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohorts)
8. Patent Application Titled 'Anti-Ror1 Antibodies And Uses Thereof' Published Online (USPTO 20240352119)
9. In vivo antibody labeling route and fluorophore dictate labeling efficiency, sensitivity, and longevity
10. Hydroxy polyethylene glycol: a solution to evade human pre-existing anti-PEG antibodies for efficient delivery
11. Archon Biosciences Debuts
12. Researchers Submit Patent Application, 'Engineered Antibodies As Molecular Degraders Through Cellular Receptors', for Approval (USPTO 20240342293)
13. Patent Issued for Formulation for antibody and drug conjugate thereof (USPTO 12115227)
14. Patent Application Titled 'Cd16 Antibody And Use Thereof' Published Online (USPTO 20240343811)
15. Patent Application Titled 'Antibody Formulations' Published Online (USPTO 20240343795)
16. New Biomarkers Data Have Been Reported by Investigators at Indian Institute of Science Education and Research (Immunogenic Sulfated l-idose Homo Oligosaccharides Elicit Neutralizing Antibody Against Native Heparan Sulfate With ...)
17. Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease TED
18. Data on Antibodies Discussed by Researchers at Guangxi Medical University (Oral Lichenoid lesions induced by programmed cell death protein 1 and cytotoxic T-lymphocyte-associated protein 4 bispecific antibody: a case report)
19. Cryo-electron microscopy reveals a single domain antibody with a unique binding epitope on fibroblast activation protein alpha
20. US FDA grants orphan drug designation to Leads Biolabs' LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D & CD3 to treat multiple myeloma
21. Nxera Pharma & Antiverse collaborate to design novel GPCR-targeted antibody therapeutics using generative AI
22. Researchers Submit Patent Application, 'Multiprotein-Engineered Cells Secreting A Multispecific Antibody', for Approval (USPTO 20240344030)
23. Spyre Therapeutics Announces Expected Acceleration of SPY003 IL-23p19 Clinical Timelines and Presentations at UEGW supporting Spyre's Portfolio of Potentially Best-in-Class Antibodies and Combinations
24. Researchers Submit Patent Application, 'Bispecific Antibodies And Uses Thereof', for Approval (USPTO 20240336702)
25. Patent Issued for Antibodies that bind to cis and uses thereof (USPTO 12110344)
26. PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning
27. RALLY THE TROOPS
28. Gilead, AbTherx expand antibody discovery agreement
29. Imlifidase Cuts DSAs in Kidney Transplant Recipients With Antibody-Mediated Rejection
30. Thermo Fisher Scientific Debuts Ambient Shipping Solution for its Invitrogen Antibodies
31. GC Biopharma, Novelty Nobility ink joint R&D agreement for geographic atrophy therapies
32. Key to effective ad fraud prevention: AI tools have developed sharper antibodies - Part 2
33. Researchers Submit Patent Application, 'Subcutaneous Unit Dosage Forms', for Approval (USPTO 20240325528)
34. Patent Issued for Bispecific anti-CCL2 antibodies (USPTO 12103967)
35. Patent Issued for E. coli specific antibodies (USPTO 12103962)
36. Making Aptamers More Antibody-like: Targeting AXL in Vivo Using a Bottlebrush Polymer-Conjugated Aptamer
37. Even Isolated Microvascular Inflammation in Kidney Grafts Portends Adverse Outcomes
38. Purple Biotech presents data for tri-specific antibody platform CAPTN-3
39. EMA committee recommends approval of LINDIS Biotech's Korjuny to treat malignant ascites MA in adults with EpCAM-positive carcinomas
40. Oblique Therapeutics enters research collaboration pact with Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target
41. Purple Biotech to present data for antibody platform at EORTC-NCI-AACR
42. GigaGen awarded US BARDA contract valued upto $135.2 mn to develop recombinant polyclonal antibody therapies for BoNT and an additional biothreat
43. ModeX secures $35M BARDA supplement to develop COVID antibodies
44. Reports from McGill University Advance Knowledge in Alzheimer Disease [Identification of high-performing antibodies for SPARC-related modular calcium-binding protein 1 (SMOC-1) for use in Western Blot and immunoprecipitation [version 2; peer ...]
45. Patent Issued for Linkers for antibody drug conjugates (USPTO 12084403)
46. Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinoma
47. 'Anti-Cxcr2 Antibodies And Uses Thereof' in Patent Application Approval Process (USPTO 20240301076)
48. Researchers Submit Patent Application, 'Treatment Of Intestinal Lumen Immunoglobulin Deficiency With Semisynthetic Polyclonal Human Secretory Immunoglobin A', for Approval (USPTO 20240301036)
49. Researchers Submit Patent Application, 'Car T Cells That Target B-Cell Antigens', for Approval (USPTO 20240299456)
50. TORL BioTherapeutics Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2024 European Society of Medical Oncology Congress
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.